Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases: highlights from basic research to therapy

A Huertas, C Guignabert, JA Barberà… - European …, 2018 - publications.ersnet.org
The European Respiratory Society (ERS) Research Seminar entitled “Pulmonary vascular
endothelium: orchestra conductor in respiratory diseases-highlights from basic research to …

Reactive Oxygen Species and Oxidative Stress in Vascular‐Related Diseases

XM Cheng, YY Hu, T Yang, N Wu… - Oxidative medicine and …, 2022 - Wiley Online Library
Oxidative stress (OS) refers to the enhancement of oxidation and the decreased of related
antioxidant enzymes activity under pathological conditions, resulting in relatively excess …

Regulation of the methylation and expression levels of the BMPR2 gene by SIN3a as a novel therapeutic mechanism in pulmonary arterial hypertension

M Bisserier, P Mathiyalagan, S Zhang, F Elmastour… - Circulation, 2021 - ahajournals.org
Background: Epigenetic mechanisms are critical in the pathogenesis of pulmonary arterial
hypertension (PAH). Previous studies have suggested that hypermethylation of the BMPR2 …

The endothelium-dependent nitric oxide–cGMP pathway

FZ Mónica, K Bian, F Murad - Advances in Pharmacology, 2016 - Elsevier
Abstract Nitric oxide (NO)–cyclic 3′-5′ guanosine monophosphate (cGMP) signaling
plays a critical role on smooth muscle tone, platelet activity, cardiac contractility, renal …

Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension

C Zeng, J Liu, X Zheng, X Hu, Y He - Respiratory Research, 2023 - Springer
Background Pulmonary arterial hypertension (PAH), Group 1 pulmonary hypertension (PH),
is a type of pulmonary vascular disease characterized by abnormal contraction and …

DNA damage and pulmonary hypertension

B Ranchoux, J Meloche, R Paulin, O Boucherat… - International journal of …, 2016 - mdpi.com
Pulmonary hypertension (PH) is defined by a mean pulmonary arterial pressure over 25
mmHg at rest and is diagnosed by right heart catheterization. Among the different groups of …

[HTML][HTML] mTOR signaling in pulmonary vascular disease: pathogenic role and therapeutic target

A Babicheva, A Makino, JXJ Yuan - International journal of molecular …, 2021 - mdpi.com
Pulmonary arterial hypertension (PAH) is a progressive and fatal disease without a cure.
The exact pathogenic mechanisms of PAH are complex and poorly understood, yet a …

The future of bronchopulmonary dysplasia: emerging pathophysiological concepts and potential new avenues of treatment

JJP Collins, D Tibboel, IM de Kleer, IKM Reiss… - Frontiers in …, 2017 - frontiersin.org
Yearly more than 15 million babies are born premature (< 37 weeks gestational age),
accounting for more than 1 in 10 births worldwide. Lung injury caused by maternal …

[HTML][HTML] Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats

C Tang, Y Luo, S Li, B Huang, S Xu, L Li - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Objective A growing evidence demonstrates that inflammation is a major contributor to the
pathogenesis of pulmonary arterial hypertension (PAH). However, blocking inflammation …

Regulation of voltage‐gated potassium channels in vascular smooth muscle during hypertension and metabolic disorders

M Nieves‐Cintrón, AU Syed, MA Nystoriak… - …, 2018 - Wiley Online Library
Voltage‐gated potassium (KV) channels are key regulators of vascular smooth muscle
contractility and vascular tone, and thus have major influence on the microcirculation. KV …